This manual offers guidance to clinicians on implementing drug testing in their practice. It presents the mechanics of testing and outlines steps for preparing staff.

This manual offers guidelines for medication-assisted treatment for people, particularly veterans, living with post-traumatic stress disorder and co-occurring opioid use disorders. It covers screening, concomitant treatment, pharmacotherapy, and multiple misused substances.

This manual offers general principles to assist in the planning, delivery, and evaluation of pharmacologic approaches to support the recovery of people living with co-occurring disorders. It covers engagement, screening, assessment, treatment planning, and continuity of care.

This manual offers guidance and tools for identifying mental illness or substance use issues early in children and adolescents in various setting, such as in schools, the juvenile justice and child welfare system, and when receiving primary care.

Contiene una guía de recursos e información para mujeres en tratamiento para el abuso de sustancias que han sido víctimas de abuso infantil. Contiene definiciones y retos potenciales de la recuperación. Incluye consejos para encontrar un terapeuta y prevenir una recaída.

This toolkit is for practitioners living with a mental illness who wish to own and operate mental health services. The toolkit provides guidance based on evidence-base practices, and includes a brochure, presentation, and introductory video.

Esta hoja de hechos ofrece informacion a los pacientes sobre la buprenorfina y los tratamientos con ayuda de medicamentos para tratar el trastorno por uso de opioides, y tambien describe el mal uso y los sintomas del sindrome de abstinencia. Explica como funciona la buprenorfina, su uso apropiado, sus efectos secundarios y como se la utiliza en conjunto con al consejeria en el proceso de recuperacion.

This manual guides counselors in the use of medications to help clients achieve abstinence from alcohol. It describes how the medications work and whom may benefit. It also presents the side effects of three FDA-approved medications: acamprosate, disulfiram, and naltrexone.